As dog owners, we've all witnessed those heart-wrenching moments when our beloved companions display signs of fear, anxiety, or behavioural distress. Whether it's cowering during thunderstorms, excessive barking when left alone, or unexplained aggression, these issues not only affect our dogs' wellbeing but also strain the precious bond we share with them. Whilst traditional treatments often focus solely on behaviour modification or medication, emerging scientific research is revealing a fascinating connection between gut health and behaviour that could revolutionise how we approach canine behavioural problems.
The Gut-Brain Axis: A Two-Way Street
Recent veterinary research has uncovered compelling evidence that the gut and brain communicate constantly through what scientists call the "gut-brain axis." This bidirectional communication system means that what happens in your dog's digestive system can directly influence their mood, emotions, and behaviour—and vice versa. A groundbreaking 2025 study examining fearful companion dogs found significant alterations in both their gut microbiome and blood metabolome compared to healthy controls (2). This discovery suggests that behavioural issues may have a physiological component rooted in digestive health that we've previously overlooked.
The implications are profound: if we can support gut health, we may be able to positively influence behaviour. This is where CaniNectar enters the picture as a potential game-changer.
Understanding Behavioural Side Effects from Common Treatments
Before exploring how CaniNectar can help, it's crucial to understand that many dogs experiencing behavioural issues may already be caught in a vicious cycle. Research has shown that dogs treated with corticosteroids—commonly prescribed for various medical conditions—can experience significant behavioural changes including increased vigilance, agitation, excessive barking, and even aggressive behaviour (1). These medications can also impact the gut microbiome, potentially exacerbating the very problems we're trying to solve.
Notari et al. (1) documented that dogs receiving corticosteroid treatment displayed heightened fearfulness, reduced playfulness, and decreased exploratory behaviours—all signs of compromised welfare. The study emphasised that "corticosteroids can bias sensitivity towards aversion in dogs" and recommended that veterinarians closely monitor behavioural changes in patients receiving these medications.
The Microbiome-Behaviour Connection
The Italian research team made fascinating discoveries when they examined fearful dogs compared to healthy controls (2). They found:
- Differential abundance of bacterial taxa, particularly alterations in Proteobacteria and Firmicutes phyla
- Significant changes in metabolites associated with GABA and glutamate neurotransmission—the brain's primary inhibitory and excitatory chemical messengers
- Alterations in bile acid metabolism
- Reduced levels of amino acids including glutamine, glycine, and lysine
These findings are remarkable because they demonstrate that fearful dogs don't just behave differently—they're physiologically different at a metabolic level. The researchers noted a correlation between specific gut bacteria (such as Peptostreptococcales Tissierellales) and metabolites like taurodeoxycholic acid, suggesting a direct link between what's happening in the gut and what's circulating in the bloodstream (2).
The Butyrate Connection: A Key Player in Gut-Brain Communication
One of the most significant discoveries in gut-brain research is the role of butyrate, a short-chain fatty acid (SCFA) produced when beneficial gut bacteria ferment dietary fibres. Butyrate serves as a primary energy source for colonocytes (the cells lining the colon) and plays crucial roles in maintaining gut health and influencing brain function (3, 4).
Research has demonstrated that butyrate:
- Enhances the integrity of epithelial tissue and mitigates mucosal inflammation (4)
- Strengthens the intestinal barrier by promoting tight junction assembly between epithelial cells, reducing "leaky gut" that can trigger systemic inflammation (3, 4)
- Exhibits anti-inflammatory effects by inhibiting nuclear factor kappa B (NF-κB) activation and reducing pro-inflammatory gene expression (4)
- Can cross the blood-brain barrier and influence neuronal function (4)
- Supports the production of GABA, the brain's primary calming neurotransmitter—particularly relevant given that the Sacchettino et al. study found altered GABA metabolism in fearful dogs (2)
The connection to canine behaviour is profound. Dogs with anxiety, fear, or stress-related behaviours often show compromised gut barrier integrity and systemic inflammation—both conditions that adequate butyrate production helps address. The altered gut microbiome identified in fearful dogs (2) likely indicates a reduced capacity to produce sufficient butyrate, potentially contributing to both intestinal dysfunction and behavioural symptoms.
Research indicates that only about 5% of SCFAs are excreted in faeces—the remaining 95% are absorbed into the bloodstream where they can exert systemic effects (3). This means that supporting butyrate production through dietary intervention has far-reaching effects beyond the gut itself.

How CaniNectar Addresses These Issues
CaniNectar's unique formulation, made from malted barley using ancient artisan varieties, provides a comprehensive approach to supporting the gut-brain axis through multiple mechanisms:
1. Digestive Enzyme Support
CaniNectar contains naturally occurring digestive enzymes including protease, lipase, amylase, and cellulase. These enzymes are crucial for breaking down food efficiently, which directly impacts the gut microbiome. When food is properly digested, it supports beneficial bacteria whilst reducing the substrate available for potentially harmful organisms. This is particularly relevant given that the 2025 study found altered levels of specific bacterial families in fearful dogs (2).
The presence of fructanase and beta-glucanase in CaniNectar also helps dogs digest complex carbohydrates and fibres from plant-based ingredients—components that can otherwise ferment inappropriately and contribute to gut dysbiosis.
2. Supporting Butyrate Production Through Prebiotic Fibres
One of CaniNectar's most significant benefits lies in its ability to support butyrate production through its rich prebiotic fibre content. Made from malted barley using ancient artisan varieties, CaniNectar is naturally abundant in beta-glucans and arabinoxylans—complex fibres that serve as ideal fuel for butyrate-producing bacteria in the colon.
Unlike simple carbohydrates that are digested and absorbed in the small intestine, these prebiotic fibres reach the large intestine intact, where beneficial bacteria ferment them into butyrate and other beneficial short-chain fatty acids through a process called saccharolytic (sugar-based) metabolism (3, 5).
This is particularly relevant given the Sacchettino et al. study's findings of altered bacterial populations in fearful dogs, including significant changes in Firmicutes—a bacterial phylum that contains many important butyrate-producing organisms such as Faecalibacterium prausnitzii, Roseburia species, Eubacterium rectale, and Coprococcus species (2, 3, 4). By providing the specific substrate these bacteria need to thrive, CaniNectar helps restore a healthy population of butyrate-producing microbes.
The process is further enhanced by CaniNectar's naturally occurring beta-glucanase enzyme, which breaks down beta-glucan chains into smaller, more readily fermentable fragments. This enzyme-prebiotic synergy creates optimal conditions for beneficial bacteria to flourish and maximise butyrate production.
Research in dogs has demonstrated that dietary interventions targeting the gut microbiota with enhanced fibre mixes can successfully increase fecal butyrate concentrations and shift metabolism from proteolytic (protein breakdown) to saccharolytic (fibre fermentation) patterns (5). These metabolic changes are associated with improved gastrointestinal health and reduced inflammation (5).
The implications for behaviour are direct and meaningful:
- Gut barrier integrity: Butyrate strengthens tight junctions between intestinal cells and promotes mucus production, reducing the translocation of inflammatory compounds that can affect brain function (3, 4)
- Reduced systemic inflammation: By maintaining gut barrier health and inhibiting NF-κB activation, butyrate helps prevent the chronic low-grade inflammation associated with anxiety and behavioural problems (4)
- Neurotransmitter support: Butyrate influences neurotransmitter production, including GABA, potentially helping dogs maintain emotional balance and resilience (4)
- Immune modulation: Butyrate regulates immune cell differentiation and function, promoting regulatory T cells that suppress excessive immune responses and reduce inflammation (4)
3. B Vitamin Complex for Neurotransmitter Production
Perhaps most significantly, CaniNectar provides a full spectrum of B vitamins, which are essential cofactors in neurotransmitter synthesis. The 2025 research revealed that fearful dogs had significantly altered metabolites related to GABA and glutamate neurotransmission (2). B vitamins, particularly B6, B12, and folate, are critical for:
- Converting amino acids into neurotransmitters
- Supporting the synthesis of serotonin and dopamine
- Maintaining healthy nerve function
- Reducing oxidative stress in the nervous system
- Thiamine (B1) specifically supports brain function and helps convert food into energy, whilst niacin (B3) aids in DNA repair and cellular metabolism—processes that may be compromised in dogs experiencing chronic stress.
4. Antioxidant Protection
CaniNectar's powerful antioxidants, including ferulic acid and flavan-3-ols, help protect cells from oxidative damage. Chronic stress and anxiety are associated with increased oxidative stress, which can damage both gut cells and neurons. By providing antioxidant support, CaniNectar may help break this destructive cycle.
5. Mineral Support for Metabolic Balance
The essential minerals in CaniNectar—magnesium, potassium, selenium, zinc, and iron—play crucial roles in:
- Muscle and nerve function (magnesium)
- Cellular hydration and heart health (potassium)
- Immune system support (selenium and zinc)
- Oxygen transport and energy levels (iron)
The Sacchettino et al. study found dysregulation in multiple metabolic pathways in fearful dogs, including glycine, serine, and threonine metabolism (2). Adequate mineral support is essential for these pathways to function optimally.

The Corticosteroid Connection
For dogs who have received or are currently receiving corticosteroid treatment, CaniNectar may offer particular benefits. Research has shown that corticosteroids can negatively impact the gut microbiota (1), and the behavioural side effects documented by Notari et al. are concerning. Whilst CaniNectar cannot replace proper veterinary care, supporting digestive health during and after such treatments may help mitigate some of these effects.
The study noted that dogs on corticosteroids showed "a decrease in behaviours associated with positive affective states, such as play and exploratory behaviours, together with an increase in aggression and barking" (1). By supporting gut health and providing nutritional cofactors for neurotransmitter production, CaniNectar may help dogs maintain better emotional balance.
A Holistic Approach
It's important to emphasise that CaniNectar should be part of a comprehensive approach to behavioural wellness, not a standalone solution. The research makes clear that behavioural issues are complex and multifactorial. Dogs experiencing fear, anxiety, or aggression should always be evaluated by a veterinarian to rule out underlying medical conditions and, where appropriate, work with a qualified animal behaviourist (1).
However, the emerging science around the gut-brain axis suggests that supporting digestive health should be a fundamental component of any behavioural wellness programme. As the 2025 study researchers concluded, "our preliminary and integrated investigations highlighted an intriguing role for the microbiome-metabolome network, allowing to further unveil the potential pathophysiology of relational issues in companion animals and paving the way for more effective therapeutic approaches" (2).
Practical Implementation
When introducing CaniNectar to your dog's diet, consistency is key. The gut microbiome doesn't change overnight, and the benefits to behaviour may take several weeks to manifest. Monitor your dog's stools, energy levels, and behavioural responses, and maintain detailed records to share with your veterinarian.
Remember that dogs with pre-existing behavioural problems may be more sensitive to any changes, so introduce CaniNectar gradually and observe your dog's response carefully.
Conclusion
The connection between gut health and behaviour represents one of the most exciting frontiers in veterinary medicine. Whilst we're still learning about the complex mechanisms involved, the evidence suggests that supporting digestive health through products like CaniNectar could play a valuable role in promoting emotional wellbeing in our canine companions.
By providing digestive enzymes, B vitamins, antioxidants, and essential minerals, CaniNectar offers comprehensive support for the gut-brain axis. Whether your dog is experiencing behavioural challenges, recovering from medical treatments that may have impacted their gut health, or simply deserving of optimal wellness support, CaniNectar represents a science-informed approach to nurturing the profound connection between digestion and behaviour.
After all, a happy gut truly may mean a happier dog.
References
- Notari, L., Kirton, R., & Mills, D. S. (2022). Psycho-behavioural changes in dogs treated with corticosteroids: A clinical behaviour perspective. Animals, 12(5), 592. https://pmc.ncbi.nlm.nih.gov/articles/PMC8909229
- Sacchettino, L., Costanzo, M., Veneruso, I., D'Argenio, V., Mayer, M., Napolitano, F., & d'Angelo, D. (2025). Altered microbiome and metabolome profiling in fearful companion dogs: An exploratory study. PLoS ONE, 20(1), e0315374. https://doi.org/10.1371/journal.pone.0315374
- Lange, O., Proczko-Stepaniak, M., & Mika, A. (2023). Short-Chain Fatty Acids-A Product of the Microbiome and Its Participation in Two-Way Communication on the Microbiome-Host Mammal Line. Current obesity reports, 12(2), 108–126. https://doi.org/10.1007/s13679-023-00503-6
- Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., Angriman, I., & Savarino, E. V. (2024). Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications. Life, 14(5), 559. https://www.mdpi.com/2075-1729/14/5/559
- Jewell, D., Jackson, M., Hall, J., & Badri, D. (2020). Feeding Microbiome-Targeting Ingredients Increases Fecal Butyrate, Plant-Origin Antioxidants, and Anti-Inflammatory Compounds in Dogs. Current Developments in Nutrition, 4(2). https://www.sciencedirect.com/science/article/pii/S2475299123082070






Share:
Supporting Your Dog's Gut Health: The Science Behind CaniNectar